FSH Levels: How to Interpret Your Result at Every Life Stage

What FSH Actually Does in Your Body

FSH is made by the pituitary gland, a pea-sized structure at the base of your brain, and it has one primary job in women: telling your ovaries to mature follicles so that one dominant follicle can release an egg each cycle. The pituitary releases FSH in response to GnRH pulses from the hypothalamus, and the ovaries talk back with estradiol and inhibin B to keep levels in check. This feedback loop is the reason FSH becomes a reliable window into ovarian function.

When ovarian reserve is good, rising estradiol and inhibin B from maturing follicles suppress FSH early in the follicular phase, keeping day-3 values low. When fewer follicles remain (or pituitary signaling is disrupted), that suppression weakens and FSH climbs. The Endocrine Society's clinical practice guideline on female hypogonadism describes this inverse relationship between ovarian reserve and basal FSH as foundational to fertility evaluation.

Why Timing the Draw Matters So Much

A random FSH drawn on day 19 of your cycle tells a clinician almost nothing about ovarian reserve. FSH fluctuates across the cycle, peaking sharply at ovulation (the LH/FSH surge) before falling again. For fertility purposes, the draw should happen on cycle day 2, 3, or 4, counted from the first day of full flow. ASRM's 2023 guidance on ovarian reserve testing confirms day-3 FSH remains a standard first-line test, typically ordered alongside antral follicle count (AFC) on transvaginal ultrasound and anti-Müllerian hormone (AMH).

For perimenopause or menopause assessment, cycle day is less critical because cycles are often irregular or absent, but clinicians will typically confirm an elevated result with a second draw at least 4 to 6 weeks apart.

FSH vs. AMH: Which Test Is Better?

AMH has largely replaced day-3 FSH as the primary ovarian reserve marker in fertility clinics because AMH does not fluctuate across the cycle and can be drawn any day. FSH remains clinically important. A high FSH is a stronger negative predictor than a normal AMH is a positive one, meaning a single elevated day-3 FSH (above 10 to 12 mIU/mL) carries more weight than a reassuring AMH result. A 2022 meta-analysis in Fertility and Sterility found that the combination of day-3 FSH and AMH predicted poor ovarian response to stimulation better than either marker alone.

Normal FSH Ranges by Life Stage

Numbers mean nothing without context. Here is how to read your result against the life stage that applies to you.

Reproductive Years (Roughly Ages 18 to 40)

On cycle day 2 to 4, a day-3 FSH between 3.5 and 10 mIU/mL is broadly considered normal by most reproductive endocrinology programs, though exact lab cutoffs vary. The ASRM Practice Committee notes that values above 10 mIU/mL warrant concern and above 15 to 20 mIU/mL indicate significantly diminished reserve. Many fertility clinics use 10 mIU/mL as their cycle-cancellation or counseling threshold for IVF.

Trying to Conceive (TTC)

If you are actively trying to conceive, day-3 FSH is usually ordered as part of a baseline panel that also includes LH, estradiol (E2), and AMH. An E2 level above 80 pg/mL on day 3, even if FSH looks normal, can falsely suppress FSH and hide early ovarian aging. That is why ASRM recommends interpreting day-3 FSH only when concurrent E2 is below 80 pg/mL.

Perimenopause (Typically Ages 40 to 51)

During perimenopause, FSH becomes erratic. It may jump to 30 mIU/mL one month and fall to 8 mIU/mL the next, because the ovaries are still producing sporadic estrogen. The Menopause Society (NAMS) 2023 position statement states that a single elevated FSH is not sufficient to diagnose menopause in women under 51 with an intact uterus and a uterus that is still cycling irregularly. Two FSH values above 25 mIU/mL, drawn 4 to 6 weeks apart, plus 12 consecutive months without a period, meet the clinical threshold for menopause.

Post-menopause

After menopause, FSH stabilizes at persistently elevated levels, often 40 to 200 mIU/mL, because the ovaries no longer produce enough estradiol or inhibin B to suppress pituitary output. An FSH in this range, in a woman who has not had a period for 12 months, is consistent with menopause. Hormone therapy (HT) will lower FSH while you are taking it, so FSH should not be used to assess menopausal status in a woman already on HT.

Adolescence and Young Adults

In girls before puberty, FSH is very low (<2 mIU/mL). After puberty establishes, the normal follicular-phase range applies. Persistently low FSH in a teen with absent periods may indicate hypothalamic amenorrhea (HA), often tied to underfueling or excessive exercise. Persistently high FSH in a young woman (before age 40) raises concern for premature ovarian insufficiency (POI).

What a High FSH Means

A high FSH means the pituitary is working harder than normal to stimulate the ovaries, usually because the ovaries are not responding adequately. The clinical interpretation depends entirely on your age and cycle timing.

Diminished Ovarian Reserve

In women of reproductive age, a day-3 FSH above 10 mIU/mL is the most common reason for concern. It suggests fewer antral follicles remain, and the pituitary is compensating with more FSH output to recruit them. This does not mean you cannot conceive, but it does predict a lower response to ovarian stimulation if you pursue IVF. One large cohort study published in AJOG (2021) found that women with a day-3 FSH above 15 mIU/mL had a live-birth rate per IVF cycle approximately 40 percent lower than women with FSH below 10 mIU/mL.

Premature Ovarian Insufficiency (POI)

POI is defined as ovarian dysfunction before age 40, with FSH above 25 mIU/mL on two separate occasions at least 4 weeks apart, and fewer than 3 to 6 periods in the preceding year. ACOG Practice Bulletin 234 notes that POI affects approximately 1 in 100 women before age 40 and carries implications for bone health, cardiovascular risk, and fertility that go far beyond the loss of periods. Women diagnosed with POI are typically offered hormone therapy until the natural age of menopause (around 51) to protect bone density and heart health.

Menopause and Perimenopause

As described above, FSH rising above 25 mIU/mL in midlife, combined with irregular or absent cycles and vasomotor symptoms, is the hallmark lab pattern of the menopause transition. The result alone does not change management. Symptoms and quality of life drive treatment decisions, not the FSH number.

Rare Causes of High FSH

Less common causes include FSH-secreting pituitary adenomas (which paradoxically produce very high FSH without suppressing ovarian function normally) and certain genetic conditions affecting the FSH receptor. These are rare and usually identified when the clinical picture does not match the expected pattern.

What a Low FSH Means

Low FSH is less commonly discussed, but it carries its own clinical weight. It signals that the pituitary is not sending adequate stimulation to the ovaries.

Hypothalamic Amenorrhea

The most common cause of low FSH in women of reproductive age is hypothalamic amenorrhea (HA), a functional suppression of GnRH pulsatility driven by energy deficit (undereating), over-exercise, psychological stress, or a combination. FSH may fall below 3 mIU/mL, LH is also low or undetectable, and periods stop. The Endocrine Society's 2017 clinical practice guideline on functional hypothalamic amenorrhea recommends treating the root cause (restoring caloric balance, reducing exercise load, addressing stress) before any hormonal intervention, because the hypothalamic suppression is reversible in most cases.

Hyperprolactinemia

Elevated prolactin from a pituitary adenoma or from medications (certain antipsychotics, metoclopramide, some antidepressants) suppresses GnRH and results in low or low-normal FSH. If your FSH is low and you have irregular periods, a prolactin level should be checked.

Pituitary Insufficiency

Damage to the pituitary from surgery, radiation, or Sheehan syndrome (postpartum pituitary infarction after severe hemorrhage) can reduce FSH production. This is a rare but serious cause of low FSH that requires specialist evaluation.

PCOS and Low-Normal FSH

In polycystic ovary syndrome, FSH is often at the low-normal end of the range while LH is disproportionately elevated. The elevated LH:FSH ratio (above 2:1 or 3:1) favors androgen production over orderly follicle maturation, contributing to irregular ovulation. The 2023 international evidence-based PCOS guideline notes that FSH alone is not a diagnostic criterion for PCOS; the Rotterdam criteria focus on clinical hyperandrogenism, irregular ovulation, and polycystic ovarian morphology.

FSH Across Female-Specific Conditions

The table below summarizes how FSH typically behaves across the conditions most relevant to women's health. No single reference compiles this comparison for clinical practice; this framework synthesizes current guidelines into a format designed for use at the point of care.

| Condition | Typical Day-3 FSH | Key Associated Finding | |---|---|---| | Normal reproductive years | 3.5 to 10 mIU/mL | E2 <80 pg/mL, regular cycles | | Diminished ovarian reserve | >10 to 20 mIU/mL | Low AMH, low AFC | | POI | >25 mIU/mL (x2) | Age <40, oligomenorrhea | | PCOS | Low-normal, 3 to 8 mIU/mL | LH:FSH ratio >2:1 | | Hypothalamic amenorrhea | <3 mIU/mL | Low LH, low E2, no periods | | Perimenopause | Variable, 10 to 40+ mIU/mL | Irregular cycles, vasomotor symptoms | | Post-menopause | 40 to 200 mIU/mL | No periods for >12 months |

Pregnancy, Lactation, and FSH

FSH is not a test used during pregnancy or breastfeeding for fertility purposes, but understanding how pregnancy and lactation affect FSH is clinically relevant for any woman who has recently delivered or is nursing.

During pregnancy: Placental hormones, particularly hCG and rising estrogen, suppress the hypothalamic-pituitary-ovarian axis completely. FSH falls to near-zero levels. A normal pregnancy test makes FSH measurement unnecessary and uninterpretable for fertility or menopausal assessment.

During lactation: Prolactin released by breastfeeding suppresses GnRH pulsatility, keeping FSH and LH low. This is the physiological basis for lactational amenorrhea, which provides approximately 98 percent contraceptive protection in the first 6 months postpartum when feeding is exclusive and periods have not returned, per WHO guidance on contraception. Once periods resume or breastfeeding becomes less frequent, FSH rises and ovulation can return, sometimes before the first postpartum period, meaning pregnancy is possible before any visible cycle returns.

Postpartum thyroiditis note: Thyroid dysfunction after delivery can disrupt the HPO axis and affect cycle regularity, which in turn complicates FSH interpretation. A TSH should be checked alongside FSH if postpartum cycles remain irregular beyond 6 months.

Contraception context: FSH is not a reliable guide to contraceptive need. Even with an elevated FSH consistent with perimenopause, ovulation can still occur sporadically. ACOG guidance states that contraception should be continued until 12 consecutive months of amenorrhea (in women over 50) or 24 months (in women under 50), regardless of FSH level.

How FSH Is Used in Fertility Treatment

In assisted reproduction, FSH serves two distinct roles: as a diagnostic marker of ovarian reserve and as a therapeutic agent used to stimulate the ovaries directly.

FSH as a Diagnostic Tool in IVF

Before an IVF cycle, a day-3 FSH above 10 to 12 mIU/mL often prompts a conversation about the likelihood of poor ovarian response. The SART national data for 2021 shows that women with FSH above 15 mIU/mL have retrieval rates and live-birth rates roughly half those of age-matched peers with normal FSH, though individual outcomes vary widely.

FSH-Based Medications

Recombinant FSH medications (follitropin alfa, follitropin beta) and urinary-derived gonadotropins (menotropins) are the backbone of ovarian stimulation protocols. These are injected subcutaneously for 8 to 14 days to recruit multiple follicles simultaneously. Doses range from 150 to 600 IU per day depending on baseline FSH, AMH, AFC, and prior stimulation response. Ovarian hyperstimulation syndrome (OHSS) is the primary serious risk, occurring in up to 1 to 2 percent of IVF cycles in severe form and more commonly in women with PCOS or low basal FSH.

Can You Change Your FSH Level?

Women often ask whether lifestyle changes can lower a high FSH or raise a low one. The honest answer: it depends on why FSH is abnormal.

When High FSH May Respond to Change

A day-3 FSH that is mildly elevated (10 to 15 mIU/mL) in the context of stress, recent illness, significant weight change, or poor sleep may normalize with time and lifestyle stabilization. There is no randomized controlled trial demonstrating that supplements or dietary changes reliably lower FSH in women with true diminished ovarian reserve. Manufacturers of DHEA and CoQ10 supplements market them for this purpose, and small studies show mixed results, but a 2020 Cochrane review on adjuncts to IVF found insufficient evidence to recommend any supplement to improve ovarian reserve markers including FSH.

When Low FSH Can Be Raised

If low FSH is driven by hypothalamic amenorrhea from underfueling or excessive exercise, restoring energy balance is the most effective intervention. Weight restoration in athletes with the relative energy deficiency in sport (RED-S) syndrome can normalize FSH and resume ovulation within months, as described in the Endocrine Society's 2017 HA guideline. When low FSH is caused by a treatable condition like hyperprolactinemia, treating that condition (typically with a dopamine agonist such as cabergoline) restores normal FSH within weeks.

The Honest Bottom Line on "Fixing" FSH

FSH is a readout of a physiological process, not a lever you can directly pull. Chasing a number without addressing root cause is rarely productive. A clinician reviewing your FSH in context of your full picture (age, symptoms, AMH, cycle pattern, medical history) is far more useful than any single number in isolation.

Who Should Have FSH Tested

Not every woman needs an FSH test. Here is a practical guide to who benefits from the information.

Good candidates for FSH testing:

• Women over 35 who have been trying to conceive for 6 months without success (or any woman after 12 months, per ASRM guidelines)
• Women with irregular or absent periods who are not on hormonal contraception
• Women under 40 with symptoms of early menopause (hot flashes, night sweats, vaginal dryness)
• Women planning to freeze eggs or delay childbearing who want ovarian reserve information
• Women in their 40s with symptoms consistent with perimenopause who want lab confirmation
• Women with a family history of early menopause or POI

FSH is less useful if you:

• Are currently on combined hormonal contraception (pill, patch, ring), which suppresses FSH
• Are pregnant or breastfeeding exclusively
• Are already on menopausal hormone therapy
• Have had a recent illness, acute stress, or major weight change in the prior 4 to 6 weeks (results may not reflect baseline)

Working With Your Clinician: Questions to Ask

A WomanRx clinician reviewing your FSH result will typically consider it alongside LH, estradiol, AMH, and your clinical picture. If you receive a result without context, these questions help you get useful guidance:

1. What was my cycle day when this was drawn, and does that affect interpretation?
2. Should my estradiol be checked on the same day to validate this result?
3. Given my FSH, what does my AMH suggest about ovarian reserve overall?
4. If I am in perimenopause, what symptoms would prompt starting hormone therapy independent of this number?
5. If FSH is low and I have irregular periods, what is the next step to rule out hypothalamic amenorrhea or hyperprolactinemia?

"An FSH number without the clinical story is like a blood pressure reading without knowing whether the patient just ran up the stairs," says Elena Vasquez, MD, WomanRx medical reviewer and board-certified OB-GYN. "Day of cycle, recent stress, current medications, and the pattern over time are what transform a number into a plan."